Biotech

All Articles

Vaccine and also Keytruda combination successful in squamous cell cancer

.Immune system gate preventions are the superheroes of cancer therapy. Medications like Bristol Myer...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of substantial management hirings, shootings...

Regeneron's Opdualag rival reveals 57% reaction rate

.Regeneron is back along with long-lasting follow-up for its LAG-3 prevention as well as PD-1 preven...

AstraZeneca messages information on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has actually shared an early look at the performance of its internal antibody-drug conj...

iTeos- GSK's TIGIT star presents significant renovation

.After announcing a phase 3 launch based on beneficial midstage outcomes, iTeos and also GSK are fin...

More collective FDA may speed up rare health condition R&ampD: document

.The FDA ought to be a lot more available as well as joint to release a surge in commendations of ra...

Zenas, MBX, Bicara head to Nasdaq in warm time for biotech IPOs

.It's an uncommonly occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX as well as Bic...

Atea's COVID antiviral neglects to stop hospitalizations in stage 3

.Atea Pharmaceuticals' antiviral has actually fallen short an additional COVID-19 test, yet the biot...

Neurocrine's bid to conserve mental illness prospect falls short

.Neurocrine Biosciences' schizophrenia system pivot has actually stopped working. The biotech was ac...

Sanofi pays for $110M upfront for late-stage radioligand therapy

.Sanofi has actually brought in a late access to the radioligand celebration, paying out 100 thousan...